Tradestie Institutional Equity Comparison Engine

BCAT vs ECAT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BCAT Overall Edge

BCAT Captures Institutional Edge (1โ€“0 Pillars ยท 2โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BlackRock Capital Allocation Term Trust (BCAT) driven by superior Momentum & Technical. Fundamentally, BCAT trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ECAT at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, BCAT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ECAT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
BCAT N/M vs ECAT N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner BCAT
1Y -13.8% vs -25.7% ยท 52W Pos 1% vs 1%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BCAT NYSE
BlackRock Capital Allocation Term Trust
Institutional Equity
$12.56
-3.01% 1D
Market Cap $1.6B
1M Return -3.53%
1Y Return -13.85%
Forward P/E N/M
Unified AI Score
31.0 / 100 SELL
Tech 15.0 Fund 44.0 Flow 50.0 Mom 74.0
ECAT NYSE
BlackRock ESG Capital Allocation Term Trust
Institutional Equity
$12.08
-2.97% 1D
Market Cap $1.6B
1M Return -8.62%
1Y Return -25.66%
Forward P/E N/M
Unified AI Score
28.8 / 100 SELL
Tech 15.0 Fund 40.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BCAT -13.85% ECAT -25.66% Spread: +11.81 pp (BCAT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BCAT TTM Op. Margin: N/A ECAT TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BCAT vs ECAT. Trailing 12-month operating profitability (BCAT N/A vs ECAT N/A) and valuation multiples (BCAT N/M vs ECAT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BCAT (2) vs ECAT (1)
Institutional Metric BCAT ECAT Criterion Row Winner
Market Capitalization Scale $1.6B $1.6B Larger Scale ECAT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 1% ($13โ€“$16) 1% ($12โ€“$16) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 0.71ฮฒ ยท 25% Vol 0.90ฮฒ ยท 28% Vol Lower Realized Risk BCAT
Unified Institutional Score Composite Signal 31.0 / 100 (SELL) 28.8 / 100 (SELL) Higher Composite BCAT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BCAT vs ECAT Buy Guide
BCAT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BCAT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ECAT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ECAT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BCAT nor ECAT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.